Publication:
Caveolin-1-dependent nanoscale organization of the BCR regulates B cell tolerance.

dc.contributor.authorMinguet, Susana
dc.contributor.authorKläsener, Kathrin
dc.contributor.authorSchaffer, Anna-Maria
dc.contributor.authorFiala, Gina J
dc.contributor.authorOsteso-Ibánez, Teresa
dc.contributor.authorRaute, Katrin
dc.contributor.authorNavarro-Lérida, Inmaculada
dc.contributor.authorHartl, Frederike A
dc.contributor.authorSeidl, Maximilian
dc.contributor.authorReth, Michael
dc.contributor.authorDel Pozo, Miguel A
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC)
dc.contributor.funderMinisterio de Economía y Competitividad (España)
dc.contributor.funderAsociación Española Contra el Cáncer
dc.contributor.funderFundación ProCNIC
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España)
dc.date.accessioned2026-01-14T10:00:31Z
dc.date.available2026-01-14T10:00:31Z
dc.date.issued2017-10
dc.description.abstractCaveolin-1 (Cav1) regulates the nanoscale organization and compartmentalization of the plasma membrane. Here we found that Cav1 controlled the distribution of nanoclusters of isotype-specific B cell antigen receptors (BCRs) on the surface of B cells. In mature B cells stimulated with antigen, the immunoglobulin M BCR (IgM-BCR) gained access to lipid domains enriched for GM1 glycolipids, by a process that was dependent on the phosphorylation of Cav1 by the Src family of kinases. Antigen-induced reorganization of nanoclusters of IgM-BCRs and IgD-BCRs regulated BCR signaling in vivo. In immature Cav1-deficient B cells, altered nanoscale organization of IgM-BCRs resulted in a failure of receptor editing and a skewed repertoire of B cells expressing immunoglobulin-μ heavy chains with hallmarks of poly- and auto-reactivity, which ultimately led to autoimmunity in mice. Thus, Cav1 emerges as a cell-intrinsic regulator that prevents B cell-induced autoimmunity by means of its role in plasma-membrane organization.
dc.description.peerreviewed
dc.description.tableofcontentsWe thank the BIOSS toolbox for reagents; M.C. Guadamillas and A. Cerezo for the generation of the B6.Cav1Y14F/Y14F mice; E. Hobeika (Max Planck Institute of Immunology and Epigenetics) for Cd79a−/− mice; H. Jumaa (Max Planck Institute of Immunology and Epigenetics) for 3-83Igi mice; C. Johner, U. Stauffer, N. Joswig, and K. Fehrenbach for experimental help; Y. Kulathu, M. Swamy M. Rizzi, K. Schachtrup and Y.R. Carrasco for critical reading of the manuscript; and W. Schamel for intellectual input and scientific discussions. Supported by the German Research Foundation (DFG) (SFB1160 IMPATH P5 to S.M., supporting F.A.H. and A.-M.S.; MI1942/2-1 to S.M., supporting G.J.F.; the Spemann Graduate School (Excellence Initiative GSC-4 to K.R.); the BIOSS Centre for Biological Signalling Studies (EXC294 to S.M. and M.R.); TRR130-P02 to M.R.; and SFB746-P07 to M.R), the European Research Council (32297 to M.R.), the Spanish Ministry of Economy and Competitiveness (SAF2008-02100 (support for S.M. in 2008); SAF2011-25047, CSD2009-00016 and SAF2014-51876-R to M.A.D.P.; and support for CNIC), the Worldwide Cancer Research Foundation (15-0404 to M.A.D.P.), the Ramón y Cajal Program from the MINECO (2009-2011 to S.M.), Asociación Española Contra el Cáncer (I.N.-L.), the Pro-CNIC Foundation (support for CNIC) and Severo Ochoa Center of Excellence (SEV-2015-0505 for CNIC).
dc.format.number10
dc.format.page1150-1159
dc.format.volume18
dc.identifier.citationNat Immunol. 2017 Oct;18(10):1150-1159.
dc.identifier.journalNature mmunology
dc.identifier.pubmedID28805811
dc.identifier.urihttps://hdl.handle.net/20.500.12105/27143
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.isreferencedbyPubMed
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/32297
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2008-02100
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2011-25047
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CSD2009-00016
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2014-51876-R
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SEV-2015-0505
dc.relation.publisherversionhttps://doi.org/10.1038/ni.3813
dc.repisalud.institucionCNIC
dc.repisalud.orgCNICCNIC
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleCaveolin-1-dependent nanoscale organization of the BCR regulates B cell tolerance.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Caveolin_1_dependent nanoscale organization_Nat Immunol_2017.pdf
Size:
2.39 MB
Format:
Adobe Portable Document Format